ArticlePharmaceutical nanotechnology2026
Green Synthesis of Curcumin-loaded Bacterial Nanocellulose for Topical Application: Preparation and In vivo Study.
Article in Pharmaceutical nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundBacterial nanocellulose (BNC) is typically produced through fermentation using Hestrin Schramm (HS) médium. However, its high cost limits its use in industry. Moreover, curcumin, as a model substance, is a potential bioactive compound but has low bioavailability. This also limits its use for clinical application. Thus, a delivery system using more affordable production of BNC was develop to improve the lack property of curcumin, focusing on topical route.
objectiveThis study aims to determine the best substrate component according to yield value and evaluate the physical properties as well as the permeation capability of BNC as a delivery matrix system for curcumin.
methodsThe optimization of Gluconacetobacter xylinus culture media to produce BNC was conducted using 6 variation substrates consisting of Palmyra sap (PS) and tofu pulp with certain concentrations. Following a nine-day period, the yield of BNC was calculated. The selected BNCs were then impregnated with curcumin-DMSO and curcumin in the form of nanoemulsion (curcumin- NE). Subsequently, the BNCs containing these curcumin forms were characterized. In vitro testing of curcumin reléased from BNC was conducted using Franz difusión cells. In addition, the penetration ability of curcumin across the mice skin was observed using confocal microscopy. In vivo testing was also conducted to ascertain the safety of BNC-loaded curcumin on mice skin. RESULTS AND DISCUSSION: PS-TP substrate (100:0, S-6) was the most appropriate substrate for BNC production, yielding 118.5±0.09 g/L. CR-DMSO and CR-NE were successfully impregnated into BNC. Confocal data showed that both formulations were able to penétrate the dermis layer. There was no significant difference was observed between the administration of BNC/CR-DMSO and BNC/CR-NE against the control.
conclusionBNC successfully produced using palmyra sap shows promising biomembrane for topical delivery of curcumin. No evidence inflammation or neovascularization in BNC/CR-DMSO- and BNC/CR-NE-treated mice confirms the safety use of this biomembrane.
Indexed as
Identifiers
39660517What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.